An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device
TioSMI
Phase 1 other active
Quick answer
An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device for Chronic obstructive pulmonary disease is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratorios Tillomed Spain S.L.U
- Indication
- Chronic obstructive pulmonary disease
- Phase
- Phase 1
- Modality
- other
- Status
- active